Preclinical Development of a Novel Epitope-based DNA Vaccine Candidate against SARS-CoV-2 and Evaluation of Immunogenicity in BALB/c Mice

This study demonstrated that the DNA vaccine construct encoding highly conserved immunogenic B and T cell epitopes was capable of eliciting potent humoral and cellular immune responses in mice.PMID:38472523 | DOI:10.1208/s12249-024-02778-x
Source: AAPS PharmSciTech - Category: Drugs & Pharmacology Authors: Source Type: research